=== CHUNK 1 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 2', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
1
objective
the objective of this document is to describe the product quality review process within 
the grünenthal group. regular periodic quality reviews shall be conducted annually 
(unless diffferently specified and supported by risk assessment) to verify the consistency 
of the existing process and the appropriateness of current specifications for both starting 
materials and finished product and to identify product and process improvements to 
ensure complete oversight on the quality of the medicinal product and safety of the 
patient. moreover, based on the review outcome, any trends are highlighted to identify 
possible product and process improvements. 
2
scope
this document applies to all grünenthal entities which are involved in the product quality 
review process. it is covering all products manufactured by the grünenthal group or by 
a cmo where grünenthal or a customer is the mah or has a specific responsibility 
according to local requirements within the purview of technical agreement in place 
between the parties.
3
responsibility 
grünenthal is responsible for conducting the product quality review of all products 
manufactured  by grünenthal group and for which grünenthal is the marketing 
authorization holder or acting as cmo for a customer. 
where grünenthal acts as the marketing authorisation holder and the manufacturing 
steps are performed  by a cmo, the respective responsibilities in performing the product 
quality review are defined in the technical agreement in place between the parties.
the senior management has the ultimate accountability of the overall process whose 
outcome is regularly evaluated during the management review.
the main responsibilities of function/roles listed in this document are as follows:

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 2.
Revision 03

Local Title: Product Quality Review
1
Objective
The objective of this document is to describe the Product Quality Review Process within 
the Grünenthal Group. Regular periodic quality reviews shall be conducted annually 
(unless diffferently specified and supported by risk assessment) to verify the consistency 
of the existing process and the appropriateness of current specifications for both starting 
materials and finished product and to identify product and process improvements to 
ensure complete oversight on the quality of the medicinal product and safety of the 
patient. Moreover, based on the review outcome, any trends are highlighted to identify 
possible product and process improvements. 
2
Scope
This document applies to all Grünenthal entities which are involved in the Product Quality 
Review Process. It is covering all products manufactured by the Grünenthal group or by 
a CMO where Grünenthal or a customer is the MAH or has a specific responsibility 
according to local requirements within the purview of technical agreement in place 
between the parties.
3
Responsibility 
Grünenthal is responsible for conducting the Product Quality Review of all products 
manufactured  by Grünenthal Group and for which Grünenthal is the Marketing 
Authorization Holder or acting as CMO for a customer. 
Where Grünenthal acts as the Marketing Authorisation Holder and the manufacturing 
steps are performed  by a CMO, the respective responsibilities in performing the Product 
Quality Review are defined in the technical agreement in place between the parties.
The Senior Management has the ultimate accountability of the overall process whose 
outcome is regularly evaluated during the management review.
The main responsibilities of function/roles listed in this document are as follows:


================================================================================

=== CHUNK 2 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 3', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
function/role 
responsibility
global 
quality 
assurance

ensure compliance with the quality management 
system at grünenthal and external guidelines/ 
standards/ regulations applicable

ensure global oversight on the process
internal 
manufacturing 
quality assurance

implement the process on a local level and ensure 
adequate documentation management according to 
this sop

ensure compliance with quality management system 
and applicable local regulations

alignment of identified need for further capas included 
in the evaluation of the adequacy of process validated 
with the releasing qp and assessment of effectiveness 
check of any actions.

provides respective pqrs as per plan 

creates pqrs or parts of a pqr whenever the local 
site is involved in manufacturing activities

perform a content check of cmo pqr as soon as 
received from esq after formal check when 
perform manufacturing steps.
commercial 
quality 
aassurance

planning of mah reviews of the pqrs 

perform a content check of cmo pqr as soon as 
received from esq after completeness check only if all 
manufacturing steps including batch certification are 
performed by a cmo. 

review the pqr results as marketing authorization 
holder 
(mah) 
or 
according 
to 
specific 
local 
responsibility and assess the necessity for further 
corrective and preventive actions

add any national information as required
external supply quality 
assurance
implement responsibilities for pqr creation in technical 
agreements with external cmos
request pqr on timely manner to external cmos 
perform a formal check of cmo pqr before forwarding 
the pqr to go -cqa and/or go- imq
responsible for the completion of annex 1 with regard to 
the qualification status of supplier   
contributing 
departments
creation of relevant pqrs annexes

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 3.
Revision 03

Local Title: Product Quality Review
Function/Role 
Responsibility
Global 
Quality 
Assurance

Ensure compliance with the Quality Management 
System at Grünenthal and external guidelines/ 
standards/ regulations applicable

Ensure Global Oversight on the process
Internal 
Manufacturing 
Quality Assurance

Implement the process on a local level and ensure 
adequate documentation management according to 
this SOP

Ensure compliance with Quality Management System 
and applicable local regulations

Alignment of identified need for further CAPAs included 
in the evaluation of the adequacy of process validated 
with the releasing QP and assessment of effectiveness 
check of any actions.

Provides respective PQRs as per plan 

Creates PQRs or parts of a PQR whenever the local 
site is involved in manufacturing activities

Perform a content check of CMO PQR as soon as 
received from ESQ after formal check when 
perform manufacturing steps.
Commercial 
Quality 
Aassurance

Planning of MAH reviews of the PQRs 

Perform a content check of CMO PQR as soon as 
received from ESQ after completeness check only if all 
manufacturing steps including batch certification are 
performed by a CMO. 

Review the PQR results as Marketing Authorization 
Holder 
(MAH) 
or 
according 
to 
specific 
local 
responsibility and assess the necessity for further 
corrective and preventive actions

Add any national information as required
External Supply Quality 
Assurance
Implement responsibilities for PQR creation in technical 
agreements with external CMOs
Request PQR on timely manner to external CMOs 
Perform a formal check of CMO PQR before forwarding 
the PQR to GO -CQA and/or GO- IMQ
Responsible for the completion of annex 1 with regard to 
the qualification status of supplier   
Contributing 
Departments
Creation of relevant PQRs annexes


================================================================================

=== CHUNK 3 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 4', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
function/role 
responsibility
qualified person
approve the pqr 
evaluate with cqa – during the mah review - any 
national amendments and/or capa needed
the responsibilities are described in more details (step per step) in section 5.
4
terms and definitions
term/abbreviation
definition
api
active pharmaceutical ingredient
capas
corrective actions and/or
preventive 
actions
cmo 
contract manufacturing organization
cqa
commercial quality assurance 
contributing departments
e.g. but not limited to: quality control, 
production, regulatory affairs
cluster of affiliates
group of countries operating under the 
same cqa organization
esq 
external supply quality assurance
eu
european union
gls
grünenthal local subsidiaries 
gmp
good manufacturing practices
cmc
cheminstry manufacturing and controls
quality assurance
gqa
global 
operation
–
global 
quality 
assurance - gxp
imq 
internal manufacturing quality assurance 
grt
grünenthal 
ipc
in-process-control
lims
laboratory 
information 
management 
system
local quality assurance
qa in manufacturing sites (imq/cmc) and 
cqa in grünenthal local subsidiaries (gls)
mah 
marketing authorization holder

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 4.
Revision 03

Local Title: Product Quality Review
Function/Role 
Responsibility
Qualified Person
Approve the PQR 
Evaluate with CQA – during the MAH review - any 
national amendments and/or CAPA needed
The responsibilities are described in more details (step per step) in section 5.
4
Terms and Definitions
Term/Abbreviation
Definition
API
Active Pharmaceutical Ingredient
CAPAs
Corrective Actions and/or
Preventive 
Actions
CMO 
Contract Manufacturing Organization
CQA
Commercial Quality Assurance 
Contributing departments
e.g. but not limited to: Quality Control, 
Production, Regulatory Affairs
Cluster of affiliates
Group of countries operating under the 
same CQA organization
ESQ 
External Supply Quality Assurance
EU
European Union
GLS
Grünenthal local subsidiaries 
GMP
Good Manufacturing Practices
CMC
Cheminstry Manufacturing and Controls
Quality Assurance
GQA
Global 
Operation
–
Global 
Quality 
Assurance - GxP
IMQ 
Internal Manufacturing Quality Assurance 
GRT
Grünenthal 
IPC
In-Process-Control
LIMS
Laboratory 
Information 
Management 
System
Local Quality Assurance
QA in manufacturing sites (IMQ/CMC) and 
CQA in Grünenthal local subsidiaries (GLS)
MAH 
Marketing Authorization Holder


================================================================================

=== CHUNK 4 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 5', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
term/abbreviation
definition
mah review 
a review performed on finished products 
(pqr) by the mah according to regulatory 
standards applicable
this may also include a review according to 
specific local responsibilities.
oos
out of specification
pic/s 
pharmaceutical inspection co-operation 
scheme
pqr
product quality review
qa 
quality assurance
qc 
quality control
qms
quality management system
qp
qualified person
5
process
5.1
general 
regular periodic quality reviews of all authorized medicinal products shall be conducted 
and documented annually
(unless diffferently specified and supported by risk 
assessment).
similar products, e.g. such with a similar composition (e.g. different strengths of a 
product) or a comparable production process, can be grouped and assessed together in 
one pqr. 
if so, common properties shall be assessed together and specific features shall be 
pointed out.
any capas necessary shall be documented and adequately tracked according to the 
relevant procedure applicable. the need of any effectiveness check of such actions shall 
be evaluated, monitored and documented accordingly.
the general process flow from the planning to the final mah review is described below:

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 5.
Revision 03

Local Title: Product Quality Review
Term/Abbreviation
Definition
MAH Review 
A review performed on finished products 
(PQR) by the MAH according to regulatory 
standards applicable
This may also include a review according to 
specific local responsibilities.
OOS
Out of Specification
PIC/S 
Pharmaceutical Inspection Co-Operation 
Scheme
PQR
Product Quality Review
QA 
Quality Assurance
QC 
Quality Control
QMS
Quality Management System
QP
Qualified Person
5
Process
5.1
General 
Regular periodic quality reviews of all authorized medicinal products shall be conducted 
and documented annually
(unless diffferently specified and supported by risk 
assessment).
Similar products, e.g. such with a similar composition (e.g. different strengths of a 
product) or a comparable production process, can be grouped and assessed together in 
one PQR. 
If so, common properties shall be assessed together and specific features shall be 
pointed out.
Any CAPAs necessary shall be documented and adequately tracked according to the 
relevant procedure applicable. The need of any effectiveness check of such actions shall 
be evaluated, monitored and documented accordingly.
The general process flow from the planning to the final MAH Review is described below:


================================================================================

=== CHUNK 5 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 6', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
the responsibilities and the detailed steps needed for conducting the product quality 
review and the subsequent mah review are described in the following sections 
depending on:

all the manufacturing steps (including release) are performed by cmo

the manufacturing steps are separated between cmo and grünenthal

all the manufacturing steps (including release) are performed by grünenthal
the pqr review and the subsequent mah review shall be planned according to the sup 
004779: the pqr plan shall be created and approved within q1 of each year andany 
delays to the pqr plan must be properly documented by a deviation according to the 
internal processes in place. 
planning
preparation, collection 
and review of pqr 
documentaion
pqr review
mah review

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 6.
Revision 03

Local Title: Product Quality Review
The responsibilities and the detailed steps needed for conducting the Product Quality 
Review and the subsequent MAH Review are described in the following sections 
depending on:

All the manufacturing steps (including release) are performed by CMO

The manufacturing steps are separated between CMO and Grünenthal

All the manufacturing steps (including release) are performed by Grünenthal
The PQR review and the subsequent MAH review shall be planned according to the SUP 
004779: the PQR plan shall be created and approved within Q1 of each year andany 
delays to the PQR plan must be properly documented by a deviation according to the 
internal processes in place. 
Planning
Preparation, Collection 
and Review of PQR 
Documentaion
PQR Review
MAH Review


================================================================================

=== CHUNK 6 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 7', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
5.2
process flows
ultimate accountability: senior management 
process responsability: qa
all manufacturing steps (included release) are 
performed by a cmo
all manufacturing steps are separated between a cmo and grt
all manufacturing steps are performed by grt
start
4. update 
required
0. pqr 
plan 
creation
sup-004779
2. pqr 
request to 
cmo
yes
end
3. pqr
check 
sup-001227
6. pqr 
review 
1.  pqr plan 
review and 
approval
sup-004779
sup 005587
esq
esq/cqa
esq
esq
esq
cqa
7. 
update 
required
cqa
8. pqr approval and 
mah review
sup-004663 /sup-005587
no
5. 
distribution 
to mah of 
the country
start
4. update 
required
0. pqr
plan
creation
sup-004779
2. pqr 
request to 
cmo
end
2a. pqr
check 
sup-001227
1.  pqr 
plan 
review 
and 
approval
sup-004779
sup-005587
imq
esq/imq/
cqa
esq
esq
esq
3. pqr 
request to 
grt dep.
sup-004661
sup-004662
5. pqr
content 
check 
6. update 
required?
7. pqr 
review 
8. pqr 
approval
sup- 004663
sup-004662 
sup – 005587
9. mah 
review
sup- 004663   
sup – 005587
imq
qa of 
mah 
country
imq
imq
imq
yes
no
no
yes
start
end
1.  pqr plan 
creation, review 
and approval
sup-004779
sup- 005587
imq
2. pqr request 
to grt dep.
sup- 004661
sup- 004662
4. update 
required?
5. pqr 
review 
8. pqr 
approval
sup- 004663
sup-004662 
sup – 005587
7. mah 
review
sup- 004663 
and sup – 
005587
imq
qa of mah 
country
imq
imq
imq
imq
yes
no
3. pqr
content check 
no
imq
esq
no

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 7.
Revision 03

Local Title: Product Quality Review
5.2
Process Flows
Ultimate Accountability: Senior Management 
Process Responsability: QA
All manufacturing steps (included release) are 
performed by a CMO
All manufacturing steps are separated between a CMO and GRT
All manufacturing steps are performed by GRT
START
4. Update 
required
0. PQR 
Plan 
Creation
SUP-004779
2. PQR 
Request to 
CMO
Yes
END
3. PQR
Check 
SUP-001227
6. PQR 
Review 
1.  PQR Plan 
Review and 
Approval
SUP-004779
SUP 005587
ESQ
ESQ/CQA
ESQ
ESQ
ESQ
CQA
7. 
Update 
required
CQA
8. PQR approval and 
MAH review
SUP-004663 /SUP-005587
No
5. 
Distribution 
to MAH of 
the country
START
4. Update 
required
0. PQR
plan
Creation
SUP-004779
2. PQR 
Request to 
CMO
END
2a. PQR
Check 
SUP-001227
1.  PQR 
Plan 
Review 
and 
Approval
SUP-004779
SUP-005587
IMQ
ESQ/IMQ/
CQA
ESQ
ESQ
ESQ
3. PQR 
Request to 
GRT Dep.
SUP-004661
SUP-004662
5. PQR
Content 
Check 
6. Update 
required?
7. PQR 
Review 
8. PQR 
Approval
SUP- 004663
SUP-004662 
SUP – 005587
9. MAH 
Review
SUP- 004663   
SUP – 005587
IMQ
QA of 
MAH 
country
IMQ
IMQ
IMQ
Yes
No
No
Yes
START
END
1.  PQR Plan 
creation, review 
and Approval
SUP-004779
SUP- 005587
IMQ
2. PQR Request 
to GRT Dep.
SUP- 004661
SUP- 004662
4. Update 
required?
5. PQR 
Review 
8. PQR 
Approval
SUP- 004663
SUP-004662 
SUP – 005587
7. MAH 
Review
SUP- 004663 
and SUP – 
005587
IMQ
QA of MAH 
country
IMQ
IMQ
IMQ
IMQ
Yes
No
3. PQR
Content Check 
No
IMQ
ESQ
No


================================================================================

=== CHUNK 7 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 8', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
5.3
filing of pqr plan, pqr review and mah review
pqr plans, pqr and mah reviews shall be filed according to sup-005587.
5.4
content of finished product pqr 
the product quality review shall be conducted for api and finished products.
the pqr report shall contain a review of all the critical cgmp aspects related to the 
production of the api and/or finished product in subject to the assessment and document 
the outcome carried out during the evaluation/reporting period.
in order to focus the review on the relevant factors for the final quality of the product, the 
critical parameters to be monitored (critical quality attributes) are preliminarily selected 
with a “risk based” approach. 
the pqr review shall be documented by using:
- the sup 004661 product quality review api
- the sup 004662 - product quality review finished product
depending if it deals with api or finished product pqr.
the pqr report shall include the sections described in the following table:
section
section description
table 
of 
content
-
list the main topics covered in the product quality review document with 
the indexing and reference page number 
-
refer to the batch listing
-
include any local additional requirements if needed (each site shall add 
the name of the item as a complementary in the relevant sup - 004661 –
e.g: annex  "complaints" shall be named as “complaints & adverse 
events” in case adverse events must be listed
summary 
and 
conclusion 
– approval
-
summarize and make reference to each single annex by giving  the 
overall picture of the assessed product quality and  highlighting any 
negative observation/trend during the pqr review period and/or any 
interruption of product distribution.
-
report an assessment of the validation status and compliance of the 
process controls and product with regard to concerned changes
annexes 
-
all annexes of the pqr shall be created in the english language for global 
products and preferably in english for local products. for local products a 
pqr shall be created in that native language.
-
see § 5.4.1 for the details related the content of annexes and part ii of 
sup 004779 for approximate timelines reference

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 8.
Revision 03

Local Title: Product Quality Review
5.3
Filing of PQR plan, PQR review and MAH Review
PQR Plans, PQR and MAH reviews shall be filed according to SUP-005587.
5.4
Content of Finished Product PQR 
The Product Quality Review shall be conducted for API and Finished Products.
The PQR report shall contain a review of all the critical cGMP aspects related to the 
production of the API and/or Finished Product in subject to the assessment and document 
the outcome carried out during the evaluation/reporting period.
In order to focus the review on the relevant factors for the final quality of the product, the 
critical parameters to be monitored (Critical Quality Attributes) are preliminarily selected 
with a “risk based” approach. 
The PQR review shall be documented by using:
- the SUP 004661 Product Quality Review API
- the SUP 004662 - Product Quality Review Finished Product
depending if it deals with API or Finished Product PQR.
The PQR report shall include the sections described in the following table:
Section
Section description
Table 
of 
content
-
List the main topics covered in the Product Quality Review document with 
the indexing and reference page number 
-
Refer to the batch listing
-
Include any local additional requirements if needed (each site shall add 
the name of the item as a complementary in the relevant SUP - 004661 –
e.g: Annex  "Complaints" shall be named as “Complaints & Adverse 
Events” in case Adverse Events must be listed
Summary 
and 
Conclusion 
– Approval
-
Summarize and make reference to each single annex by giving  the 
overall picture of the assessed product quality and  highlighting any 
negative observation/trend during the PQR review period and/or any 
interruption of product distribution.
-
Report an assessment of the validation status and compliance of the 
process controls and product with regard to concerned changes
Annexes 
-
All annexes of the PQR shall be created in the English language for global 
products and preferably in English for local products. For local products a 
PQR shall be created in that native language.
-
See § 5.4.1 for the details related the content of annexes and Part II of 
SUP 004779 for approximate timelines reference


================================================================================

=== CHUNK 8 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 9', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
the naming convention to be used for the product description in the header of the sup -
004662 is:
main bulk/api name + galenic form + strength + unique identifier (if different types 
exist)
e.g. tramal capsules 50mg (yellow/yellow)
the pqr shall be created by internal manufacturing quality unit, reviewed by the 
functional heads ( e.g manufacturing head, qc head) and approved by the qualified 
person.
the signature cycle of the pqr shall be started once all annexes are available and the 
summary and conclusion is finalized.

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 9.
Revision 03

Local Title: Product Quality Review
The naming convention to be used for the product description in the header of the SUP -
004662 is:
Main Bulk/API name + galenic form + strength + unique identifier (if different types 
exist)
e.g. Tramal capsules 50mg (yellow/yellow)
The PQR shall be created by Internal Manufacturing Quality Unit, reviewed by the 
Functional Heads ( e.g Manufacturing Head, QC Head) and approved by the Qualified 
Person.
The signature cycle of the PQR shall be started once all annexes are available and the 
summary and conclusion is finalized.


================================================================================

=== CHUNK 9 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 10', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
5.5
pqr annexes 
5.5.1.1
api pqr annexes
annex
activity
responsability
0 -  description of the production 
process and batch listing
a description of the production process for the relevant manufacturing 
steps for the considered apis
imq
1a - qc of finished api
1b - in-process-control
a review of critical in-process control and critical api test results.
qc
2 - oos in qc
a review of all batches that failed to meet established specification(s).
qc
3- deviations
a review of all critical deviations or non-conformances and related 
investigations.
imq
4a– changes in analytical methods -
qc
4b - changes in analytical methods -
in process control
4c - changes in production process
4d - changes in specification
a review of all changes carried out to the processes or analytical 
methods.
imq
5 - stability
a review of the results of the stability monitoring program.
qc
6- complaints, returns and recalls
a review of all quality-related returns, complaints and recalls.
imq

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 10.
Revision 03

Local Title: Product Quality Review
5.5
PQR Annexes 
5.5.1.1
API PQR Annexes
Annex
Activity
Responsability
0 -  Description of the Production 
Process and batch listing
A description of the production process for the relevant manufacturing 
steps for the considered APIs
IMQ
1A - QC of Finished API
1B - In-Process-Control
A review of critical in-process control and critical API test results.
QC
2 - OOS in QC
A review of all batches that failed to meet established specification(s).
QC
3- Deviations
A review of all critical deviations or non-conformances and related 
investigations.
IMQ
4A– Changes in Analytical Methods -
QC
4B - Changes in Analytical Methods -
In Process Control
4C - Changes in Production Process
4D - Changes in Specification
A review of all changes carried out to the processes or analytical 
methods.
IMQ
5 - Stability
A review of the results of the stability monitoring program.
QC
6- Complaints, Returns and Recalls
A review of all quality-related returns, complaints and recalls.
IMQ


================================================================================

=== CHUNK 10 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 11', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
annex
activity
responsability
7- previous actions
a review of adequacy of corrective actions.
imq
5.5.1.2
finished product pqr annexes
annex
activity
responsability
1 -  starting material 
a review of starting materials including packaging materials used in the 
product, especially those from new sources and in particular the review 
of supply chain traceability of active substances 
imq/ esq
2a - qc of finished products
2b - in-process-controls
a review of critical in-process controls and finished product results
qc
3 - oos in qc
a review of all batches that failed to meet established specification(s) 
and their investigation
qc
4- deviations
a review of all significant deviations or non-conformances, their related 
investigations, and the effectiveness of resultant corrective and 
preventive actions taken
imq
5a – techincal change controls
5b – product change controls
a review of all changes carried out to the processes or analytical 
methods
imq/ cmc
6 - variations
a review of marketing authorisation variations submitted, granted or 
refused, including those for third country (export only) dossiers
ra
7 - stability
a review of the results of the stability monitoring program and any 
adverse trends
qc/imq

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 11.
Revision 03

Local Title: Product Quality Review
Annex
Activity
Responsability
7- Previous Actions
A review of adequacy of corrective actions.
IMQ
5.5.1.2
Finished Product PQR Annexes
Annex
Activity
Responsability
1 -  Starting Material 
A review of starting materials including packaging materials used in the 
product, especially those from new sources and in particular the review 
of supply chain traceability of active substances 
IMQ/ ESQ
2A - QC of Finished Products
2B - In-Process-Controls
A review of critical in-process controls and finished product results
QC
3 - OOS in QC
A review of all batches that failed to meet established specification(s) 
and their investigation
QC
4- Deviations
A review of all significant deviations or non-conformances, their related 
investigations, and the effectiveness of resultant corrective and 
preventive actions taken
IMQ
5A – Techincal Change Controls
5B – Product Change Controls
A review of all changes carried out to the processes or analytical 
methods
IMQ/ CMC
6 - Variations
A review of Marketing Authorisation variations submitted, granted or 
refused, including those for third country (export only) dossiers
RA
7 - Stability
A review of the results of the stability monitoring program and any 
adverse trends
QC/IMQ


================================================================================

=== CHUNK 11 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 12', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
annex
activity
responsability
8 - complaints, returns and recalls
a review of all quality-related returns, complaints and recalls and the 
investigations performed at the time
imq
9 - capas
a review of adequacy of any other previous product process or 
equipment corrective and preventive actions
imq
10 - post-marketing commitments
for new marketing authorizations and variations to marketing 
authorizations, a review of post-marketing commitments
ra
11a - qualification status – qc 
11b- qualification status – ipc
11c - qualification status production 
– formulations – bulk product
11d - qualification status - production 
– packaging 
a review of the qualification status of relevant equipments and utilities, 
e.g. hvac, water, compressed gases, etc.
imq/qc
12 - technical agreements
a review of any contractual agreements as defined in chapter 7 (of eu 
gmp guideline, part i) to ensure that they are up to date
esq/imq

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 12.
Revision 03

Local Title: Product Quality Review
Annex
Activity
Responsability
8 - Complaints, Returns and Recalls
A review of all quality-related returns, complaints and recalls and the 
investigations performed at the time
IMQ
9 - CAPAs
A review of adequacy of any other previous product process or 
equipment corrective and preventive actions
IMQ
10 - Post-marketing Commitments
For new marketing authorizations and variations to marketing 
authorizations, a review of post-marketing commitments
RA
11A - Qualification Status – QC 
11B- Qualification Status – IPC
11C - Qualification Status Production 
– Formulations – Bulk Product
11D - Qualification Status - Production 
– Packaging 
A review of the qualification status of relevant equipments and utilities, 
e.g. HVAC, water, compressed gases, etc.
IMQ/QC
12 - Technical Agreements
A review of any contractual agreements as defined in Chapter 7 (of EU 
GMP Guideline, Part I) to ensure that they are up to date
ESQ/IMQ


================================================================================

=== CHUNK 12 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 13', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
5.6
manufacturing, testing and release on behalf
if a product is manufactured, tested and/or released externally on behalf, the 
responsibilities for creating the pqr shall be regulated in accordance to the 
corresponding quality agreement.
5.7
mah review and amendment of pqrs
5.7.1
mah review
the mah is accountable for performing the pqr review (mah review) according to the 
plan (sup-004779) and evaluating the results of the review.
the mah review shall be performed by the relevant commercial quality assurance  of 
the sale affiliate/cluster1 of , when the sales affiliate is appointed as mah of 
the product in the country. 
the mah review shall be done after  2 weeks from the approval of pqr review and the 
outcome of the mah review shall be documented in the respective part 2 "mah review" 
of the relevant supportive document sup - 004663 – pqr evaluation sheet”.
the qa representative (cqa) of the mah is requested to give a statement whether:
• further corrective and/or preventive actions are required
and/or
• further revalidation is required
and/or
• nationalization of the pqr is required (e.g. adding extra pqr annexes for local stability 
studies or qc data from local product testing) 
if the qa representative (cqa) of the mah identifies:
-
any corrections/adjustments necessary to the relevant pqr report already 
approved
-
any need for further capas 
-
any  need for revalidation 
he/she shall be  accountable to align this with the product releasing qualified person.
5.7.2
amendment of pqrs according to national requirements
pqr data shall also enable the mah to identify the need for improvement in its own 
regulatory affairs  processes that operate in conjunction with the manufacturing sites.
if a pqr needs to be nationalized, this shall be done by using the template “product 
quality review finished product sup - 004662. 
                                                            
1note : in case of a cluster of affiliates, the cqa is legally accountable to maintain the 
qms and ensure compliance with regulatory requirements in all countries under the 
relevant cluster.

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 13.
Revision 03

Local Title: Product Quality Review
5.6
Manufacturing, Testing and Release on behalf
If a product is manufactured, tested and/or released externally on behalf, the 
responsibilities for creating the PQR shall be regulated in accordance to the 
corresponding Quality Agreement.
5.7
MAH Review and Amendment of PQRs
5.7.1
MAH Review
The MAH is accountable for performing the PQR review (MAH review) according to the 
plan (SUP-004779) and evaluating the results of the review.
The MAH review shall be performed by the relevant Commercial Quality Assurance  of 
the sale affiliate/cluster1 of , when the sales affiliate is appointed as MAH of 
the product in the country. 
The MAH review shall be done after  2 weeks from the approval of PQR review and the 
outcome of the MAH review shall be documented in the respective part 2 "MAH Review" 
of the relevant Supportive Document SUP - 004663 – PQR Evaluation Sheet”.
The QA representative (CQA) of the MAH is requested to give a statement whether:
• Further corrective and/or preventive actions are required
and/or
• Further revalidation is required
and/or
• Nationalization of the PQR is required (e.g. adding extra PQR annexes for local stability 
studies or QC data from local product testing) 
If the QA representative (CQA) of the MAH identifies:
-
any corrections/adjustments necessary to the relevant PQR report already 
approved
-
any need for further CAPAs 
-
any  need for revalidation 
he/she shall be  accountable to align this with the product releasing Qualified Person.
5.7.2
Amendment of PQRs according to national Requirements
PQR data shall also enable the MAH to identify the need for improvement in its own 
regulatory affairs  processes that operate in conjunction with the manufacturing sites.
If a PQR needs to be nationalized, this shall be done by using the template “Product 
Quality Review Finished Product SUP - 004662. 
                                                            
1NOTE : in case of a cluster of affiliates, the CQA is legally accountable to maintain the 
QMS and ensure compliance with regulatory requirements in all countries under the 
relevant cluster.


================================================================================

=== CHUNK 13 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 14', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
at least the changed annexes and a new summary and conclusion chapter need to be 
added. 
5.8
distribution and archive
the pqr and mah reviews shall be accessible at least to the responsible qualified 
person, head of quality assurance, head of production, head of quality control and to 
all country quality assurances where  is the marketing authorization holder.
the pqr and mah reviews shall be archived and retained for the period as prescribed 
by the   procedure for the data retention  requirements.
6
references 

eu guidelines to good manufacturing practice medicinal products for human and

veterinary use, part i, chapter 1.10

eu guidelines to good manufacturing practice medicinal products for human and

veterinary use, part ii, chapter 2.6

pic/s guide to good manufacturing practice for medicinal products part i

pic/s guide to good manufacturing practice for medicinal products part ii (api)

reflection paper on good manufacturing practice and  marketing authorisation 
holders  ema/457570/2019

ich q7 note for guidance on good manufacturing practice for active 
pharmaceuticals ingredients (cpmp/ich/4106/00)

regulation (eu) 2017/745 (mdd)
7

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 14.
Revision 03

Local Title: Product Quality Review
At least the changed annexes and a new summary and conclusion chapter need to be 
added. 
5.8
Distribution and Archive
The PQR and MAH reviews shall be accessible at least to the responsible Qualified 
Person, Head of Quality Assurance, Head of Production, Head of Quality Control and to 
all country Quality Assurances where  is the marketing authorization holder.
The PQR and MAH reviews shall be archived and retained for the period as prescribed 
by the   procedure for the data retention  requirements.
6
References 

EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and

Veterinary Use, Part I, Chapter 1.10

EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and

Veterinary Use, Part II, Chapter 2.6

PIC/S Guide to Good Manufacturing Practice for Medicinal Products Part I

PIC/S Guide to Good Manufacturing Practice for Medicinal Products Part II (API)

Reflection paper on Good Manufacturing Practice and  Marketing Authorisation 
Holders  EMA/457570/2019

ICH Q7 Note for guidance on good manufacturing practice for active 
pharmaceuticals ingredients (CPMP/ICH/4106/00)

Regulation (EU) 2017/745 (MDD)
7


================================================================================

=== CHUNK 14 ===
[METADATA]: {'file_name': 'GRT_PROC_English_stamped_V7.docmNov302025052415.pdf', 'page_label': 'Page 15', 'sop_title': 'Product Quality Review', 'document_number': 'PROC-004198', 'version_number': '03', 'status': 'Active'}

[CONTENT - LOWERCASE]:
revision 03

local title: product quality review
revision/ 
document no.
description of changes
o
§5.5 replaced with the description of pqr annexes (§5.5.1 
and §5.5.2)
o
§5.6 changed numbering of the section (in the previous 
version “the manufacturing, testing and release on 
behalf” was reported in the section §5.8)
o
§5.7 reviewed the description of the mah review and 
amendments of pqr and changed numbering of the 
section respect with the previous version 

updated the section with the new supportive 
documents numbers migrated in mc
o
removed the section of customized pqr (previous §5.9)
o
§5.8 updated the section related the distribustion by 
changing the title with “distribution and archive” and adding 
the information regarding to the archive ( this section 
corresponds to the section 5.10 of the previous version)

§6 updated the references
03

updated template version

§5.2 process flows: removed the reference to the proc-005047

[CONTENT - ORIGINAL]:
Source: GRT_PROC_English_stamped_V7.docmNov302025052415.pdf, Page 15.
Revision 03

Local Title: Product Quality Review
Revision/ 
document no.
Description of changes
o
§5.5 replaced with the description of PQR annexes (§5.5.1 
and §5.5.2)
o
§5.6 changed numbering of the section (in the previous 
version “The manufacturing, Testing and Release on 
behalf” was reported in the section §5.8)
o
§5.7 reviewed the description of the MAH review and 
amendments of PQR and changed numbering of the 
section respect with the previous version 

Updated the section with the new supportive 
documents numbers migrated in MC
o
Removed the section of Customized PQR (previous §5.9)
o
§5.8 Updated the section related the Distribustion by 
changing the title with “Distribution and Archive” and adding 
the information regarding to the archive ( this section 
corresponds to the section 5.10 of the previous version)

§6 Updated the references
03

Updated template version

§5.2 Process Flows: removed the reference to the PROC-005047


================================================================================

